The President’s Malaria Initiative: Evaluation & Research-to-Use Implementation Project | GH BAA 2018 ADDENDUM04

Opportunity Information: Apply for GH BAA 2018 ADDENDUM04

The President's Malaria Initiative: Evaluation & Research-to-Use Implementation Project is a USAID funding opportunity released as an addendum to an existing Broad Agency Announcement (Funding Opportunity Number: GH BAA 2018 ADDENDUM04). It sits within the health sector (CFDA 98.001) and is designed to strengthen how malaria programs are evaluated, how research questions are prioritized and agreed upon, and how existing data are turned into practical decisions. In plain terms, USAID is looking to support a structured partnership focused on malaria evaluation and applied research, with an emphasis on making sure evidence does not just get produced but is actually used to improve programs.

The core purpose is to create a malaria evaluation and research partnership that can be led by one organization or a group/consortium of organizations. Rather than funding a single narrow study, the opportunity is framed around building a standing capability to take on future evaluation and research activities as needs arise. That includes conducting program evaluations and implementation-focused research, convening or facilitating consensus around new collaborative research ideas (so that multiple stakeholders can align on what questions matter most), and bringing rigor to the use of existing information through synthesis and meta-analysis. The intent is to avoid duplicated efforts, connect scattered findings, and turn what is already known into clearer, more actionable guidance.

A major theme in the description is "research-to-use," meaning USAID wants outputs that translate into improved decision-making, better program design, and more effective implementation. Alongside generating new findings, the partnership is expected to improve how evaluation and research data are utilized, which can include developing practical solutions for data access, standardization, interpretation, and communication to policymakers and implementers. The opportunity explicitly calls for synthesizing existing malaria data and conducting meta-analyses, signaling that the awardee(s) should have strong technical capacity in evidence synthesis, epidemiology/biostatistics, evaluation methods, and the operational realities of malaria programming.

Eligibility is listed as unrestricted, suggesting that a wide range of applicants may apply, including nonprofits, for-profits, universities, research institutions, and consortia, as long as they can credibly deliver the partnership functions described. The agency is the U.S. Agency for International Development (USAID), and the opportunity category and instrument type are both listed as "Other," consistent with a BAA addendum that may support flexible collaboration and research activities rather than a single conventional grant format. The posting shows an original closing date of 2019-10-24 and a creation date of 2019-09-24. The award ceiling is listed as 0 and expected awards are not specified in the provided data, which typically means applicants need to refer to the full solicitation language for budget expectations, number of anticipated awards, and any ceilings that may be defined elsewhere in the addendum or accompanying documents.

Overall, this opportunity is best understood as an effort by USAID under the President's Malaria Initiative to institutionalize a high-capacity evaluation and research partner (or network) that can generate and organize evidence, align stakeholders on priority research questions, and accelerate the conversion of data into improvements in malaria control and elimination programming.

• The Agency for International Development in the health sector is offering a public funding opportunity titled "The President’s Malaria Initiative: Evaluation & Research-to-Use Implementation Project" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
• This funding opportunity was created on 2019-09-24.
• Applicants must submit their applications by 2019-10-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Unrestricted.

Apply for GH BAA 2018 ADDENDUM04

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: